Brief case history of alveolar soft part sarcomas that responded to immunotherapy

AgeDiagnosisPrior TherapiesBest response and Duration of response with Immunotherapy
33Alveolar Soft PartSunitinib, Pazopanib, cabozantinbi, Vandetanib/Everolimus,Partial Response ×12 months
32Alveolar Soft PartCediranib, SunitinibPartial Response ×8 months